(Q83676605)

English

Second-line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first-line platinum-based chemotherapy: a multicenter AGEO study

scientific article published on 08 November 2010

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425142%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Second-line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first-line platinum-based chemotherapy: a multicenter AGEO study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425142%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Mélanie Gauthier

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425142%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

David Malka

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425142%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Christophe Locher

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425142%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Jean-Marc Gornet

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425142%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Anne Thirot-Bidault

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425142%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Julien Taïeb

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425142%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Franck Bonnetain

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425142%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Thomas Aparicio

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425142%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Association des Gastro Entérologues Oncologues

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425142%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

publication date

8 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425142%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425142%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

117

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425142%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425142%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1422-1428

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425142%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25614

7 January 2021

based on heuristic

inferred from DOI database lookup

Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25614

7 January 2021

based on heuristic

inferred from DOI database lookup

Descriptive epidemiology of small intestinal malignancies: the German Cancer Registry experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25614

7 January 2021

based on heuristic

inferred from DOI database lookup

A population-based study of the incidence of malignant small bowel tumours: SEER, 1973-1990.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25614

7 January 2021

based on heuristic

inferred from DOI database lookup

Small-bowel tumors: epidemiologic and clinical characteristics of 1260 cases from the connecticut tumor registry

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25614

7 January 2021

based on heuristic

inferred from DOI database lookup

The American College of Surgeons Commission on Cancer and the American Cancer Society. Adenocarcinoma of the small bowel: review of the National Cancer Data Base, 1985-1995.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25614

7 January 2021

based on heuristic

inferred from DOI database lookup

Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25614

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary cancers of the small bowel: analysis of prognostic factors and results of surgical management

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25614

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy in small bowel adenocarcinoma: 10-year experience of the British Columbia Cancer Agency

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25614

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural history and chemotherapy effectiveness for advanced adenocarcinoma of the small bowel: a retrospective review of 113 cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25614

7 January 2021

based on heuristic

inferred from DOI database lookup

The Royal Marsden experience of a small bowel adenocarcinoma treated with protracted venous infusion 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25614

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination chemotherapy in advanced small bowel adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25614

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy with 5-fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25614

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25614

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy of advanced small-bowel adenocarcinoma: a multicenter AGEO study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25614

7 January 2021

based on heuristic

inferred from DOI database lookup

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25614

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25614

7 January 2021

based on heuristic

inferred from DOI database lookup

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25614

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25614

7 January 2021

based on heuristic

inferred from DOI database lookup

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25614

7 January 2021

based on heuristic

inferred from DOI database lookup

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25614

7 January 2021

based on heuristic

inferred from DOI database lookup

Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25614

7 January 2021

based on heuristic

inferred from DOI database lookup

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25614

7 January 2021

based on heuristic

inferred from DOI database lookup

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25614

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25614

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.25614

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425142%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21425142%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q83676605&oldid=2005498612"